A substantial advancement in glucose care is emerging with the release of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://lillicnpt719697.celticwiki.com/2262289/groundbreaking_introduction_tirzepatide_45mg_for_glucose_control